AMIFAMPRIDINE SUBSTIPHARM 10 mg, scored tablet 100 tablets
Active ingredients: Amifampridine, Amifampridine phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet100 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMIFAMPRIDINE SUBSTIPHARM 10 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- 100 plaquettes prédécoupées unitaires aluminium PVC PVDC de 1 comprimé
- Marketing authorisation holder
- AXUNIO PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65825598CIP73025019CIP133400930250198Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE D'AMIFAMPRIDINEcomprimé | — | SA |
| AMIFAMPRIDINEcomprimé | 10 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.